RedShiftBio

RedShiftBio is redefining the possibilities for analyzing protein structure and concentration. RedShiftBio has developed a proprietary life sciences platform combining our Microfluidic Modulation Spectroscopy (MMS) and expertise in high-powered quantum cascade lasers that provide ultra-sensitive and ultra-precise measurements of molecular structure. These structural changes affect critical quality attributes governing the safety, efficacy, and stability of biomolecules and their raw materials. This combination of technologies is available to researchers in our fully-automated Aurora and Apollo systems and is backed by a global network of sales, applications, service, and support teams to address all market needs. Alongside our commitment to further innovation...

Tunable infared filters,quantum cascade lasers,molecular spectroscopy,dsc - differential scanning calorimetry, cd-uv – circular dichroism ultraviolet,hplc-sec - high performance liquid chromatography-size exclusion chromatography, uv bca – ultraviolet bicinchoninic acid assay,protein characterization,ft-ir,biotherapeutics analysis,biosimilar,formulation,secondary structure,biologics,biophysical characterization,aggregation,stability,antibodies,drug discovery,process development,titration,chromatography,bioprocessing analytics,and protein a affinity chromatography

Redshiftbio operates in the Biotechnology research industry.

Redshiftbio's revenue is 11m - 100m

Redshiftbio has 11 - 50 employees.